Articles by Daniel Marsh
Tvardi Therapeutics Surges 40% on Promising Phase 1 Data for TTI-109
Tvardi Therapeutics shares surged 40% after Phase 1 data for TTI-109 showed rapid conversion and improved tolerability, with volume hitting 53.9 million shares.
T1 Energy Shares Tumble 16% as Warrant Expiry Looms
T1 Energy shares fell 16.6% to $7.21 as 24.6 million warrants expire July 9 at $11.50. Director RSUs added 146,850 new shares.
SkinHealth Systems Soars on FDA Clearance, Nasdaq Compliance in Focus
SkinHealth Systems shares surged 50% on heavy volume after FDA clearance for its SkinStylus device, but the rally's main significance lies in the company's effort to regain Nasdaq compliance.
Chip ETF Rally Reverses: Memory and Equipment Stocks Lead Selloff
Invesco Semiconductors ETF, the top chip ETF in 2026, fell 7.8% as memory and equipment stocks dragged, while VanEck Semiconductor ETF with high Nvidia weight dropped only 5.0%.
ClearOne Soars 48% on Cortigent Merger Details
ClearOne (CLRO) surged 48% after a SEC filing detailed its merger with Cortigent, with trading volume at 48 times its float. The deal includes a $10-15M financing.
Nu Holdings Stock Dips as Proxy Reveals Minimal Buyback Impact
Nu Holdings shares slipped 1.1% after a proxy filing revealed its $1 billion buyback would reduce share count by only about 1.5%, while Class B shares control 84% of voting power.
Trident Digital Tech Surges on Founder's Below-Market Debt Conversion
Trident Digital Tech shares jumped 46.7% after founder Soon Huat Lim announced a debt-to-equity swap at a 25% discount to market price, aiming to shore up the company's finances.
